Global Drug Eluting Stents Market Forecasts to 2024
- July, 2018
- Domain: Healthcare - Medical Devices
- Get Free 10% Customization in this Report
Overview of the Global Drug Eluting Stents Market
Infoholic’s market research report predicts that the global drug eluting stents market will grow at a CAGR of 5.4% during the forecast period 2018–2024. The major drivers of the market are the increasing prevalence of cardiovascular diseases, rising aging population, growing acceptance for minimally invasive endovascular surgeries, and good reimbursement facilities are few of the factors driving the growth of the drug eluting stents market. Increasing healthcare spending, rise in the number of outpatient procedures, and market expansion opportunities in emerging nations are providing an opportunity for the growth of the market. However, alternatives for drug-eluting stents, lack of skilled healthcare professionals, and stringent regulatory approval process are hampering the growth of the market.
According to the drug eluting stents market analysis, in 2017, Europe accounts for the largest share of the drug-eluting stents market, followed by Asia Pacific, and Rest of the World. More than 60% of the market is occupied by Europe, with Germany being the major contributor to the market growth.
Competitive Analysis and Key Vendors
New product development, geographical expansion, collaboration, mergers & acquisitions, and pricing strategies are vital undertakings of players in the drug eluting stents market. For instance, in May 2018, MicroPort, a Chinese company acquired the cardiac rhythm management segment of LivaNova, which has made MicroPort a prominent player in the market. In January 2017, St. Jude Medical, one of the major players in the market, was acquired by Abbott Laboratories for a total of $25 billion. In August 2018, Boston Scientific Corp. signed an agreement to acquire Veniti Inc. Recently, the prices of coronary stents in India have been slashed by around 70%, making it affordable to lower-income people. As a result, Abbott Laboratories and Boston Scientific are withdrawing their most advanced products “Absorb” and “Synergy & Promous Premier”, respectively. This has helped MicroPort to establish its market easily in India with the targeted drug eluting stents. The technology of MicroPort is proved to be no less than Abbott and other products by market leaders. This is expected to strengthen its market in India.
Some of the Drug Eluting Stents Market key vendors:
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic plc
- Johnson and Johnson
- MicroPort Scientific Corporation
- Biotronik Inc.
Other vendors in the global drug eluting stents market are Terumo Corporation, Biosensors International Group, Meril Life Science, Stentys SA, Cook Medical Inc., and Lepu Medical Technology. Currently, many manufacturers are outsourcing research to clinical research organizations, which is indirectly boosting the growth of the drug-eluting stents market.
Drug Eluting Stents Market by Coating Type
- Polymer-based coating stents
- Polymer-free coating stents
Non-biodegradable and biodegradable polymer are the two types of polymer-based coatings. Microporous surface, microstructured surface, slotted tubular surface, and nanoporous surface are the types of polymer-free coating.
Drug Eluting Stents Market by Application Type
- Coronary artery disease
- Peripheral artery disease
Approximately 90% of all percutaneous interventional surgeries use a coronary stent of all stenting procedures is done with drug eluting stents. Therefore, the majority of the market is occupied by coronary arterial intervention.
Drug Eluting Stents Market by End-Users
- Ambulatory Surgical Centers (ASCs)
- Cardiology Centers
The advantages such as availability of surgery specialists, reduced hospital stay duration, and less charge of surgery have made ambulatory surgical centers the most preferred mode for the treatment. This has made them the largest segment among end-users during the forecast period.
The report provides detailed information about the usage and adoption of drug eluting stents devices in various applications and regions. With that, key stakeholders can find out the major trends, drivers, investments, and vertical player’s initiatives toward the product adoption in the upcoming years, along with the details of commercial products available in the market. Moreover, the report provides details about the major challenges that are going to have an impact on market growth. Additionally, the report gives complete details about the business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals. The report will help companies interested or established in this market to analyze the various aspects of this domain before investing or expanding their business in the drug eluting stents market.
1.1 Industry Overview
1.2 Total Addressable Market
1.3 Industry Trends
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Segmented Addressable Market
3.3 Industry Trends
3.4 Related Markets
3.4.1 Cardiovascular Drugs
18.104.22.168 Trends in the cardiovascular drugs market
3.4.2 Aortic Aneurysm
22.214.171.124 Trends in the Aortic Aneurysm Market
3.4.3 Coronary Stents Market
3.4.4 Cardiovascular Diagnostics
4 Market Outlook
4.1 Reimbursement Scenario
4.2 Market Segmentation
4.3 Porter 5(Five) Forces
4.4 PEST Analysis
5 Market Characteristics
5.1 Market Dynamics
126.96.36.199 Increasing prevalence of cardiovascular diseases
188.8.131.52 Increasing aging population
184.108.40.206 Growing acceptance for minimally invasive endovascular surgeries
220.127.116.11 Increase in healthcare spending
18.104.22.168 Increase in the number of outpatient procedures
22.214.171.124 Market expansion opportunities in emerging nations
126.96.36.199 Stringent regulations for the approval process
188.8.131.52 Alternative treatment for drug-eluting stents
184.108.40.206 Lack of skilled healthcare professionals
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 Types: Market Size and Analysis
6.2 Polymer-based Coating
6.3 Polymer-free Coating
7 Application: Market Size and Analysis
7.2 Coronary Artery Diseases
7.3 Peripheral Artery Disease
8 End-users: Market Size and Analysis
8.2 Hospitals and Clinics
8.3 Ambulatory Surgical Center
8.4 Cardiac Centers
9 Regions: Market Size and Analysis
9.2 North America
9.4 Asia Pacific
9.5 Rest of the World
10 Competitive Landscape
11 Vendors Profile
11.1 Abbott Laboratories
11.1.2 Business Units
11.1.3 Geographic Presence
11.1.4 Business Focus
11.1.5 SWOT Analysis
11.1.6 Business Strategies
11.2 Boston Scientific Corp.
11.2.2 Business Units
11.2.3 Geographic Presence
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategies
11.3 Biotronik, Inc.
11.3.2 Business Focus
11.3.3 SWOT Analysis
11.3.4 Business Strategies
11.4 Medtronic Plc
11.4.2 Business Units
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategies
11.5 Johnson & Johnson
11.5.2 Business Units
11.5.3 Geographic Revenue
11.5.4 Business Focus
11.5.5 SWOT Analysis
11.5.6 Business Strategies
11.6 MicroPort Scientific Corporation
11.6.2 Business Units
11.6.3 Geographic Presence
11.6.4 Business Focus
11.6.5 SWOT Analysis
11.6.6 Business Strategies
12 Companies to Watch for
12.1 Terumo Corp.
12.2 Biosensors International Group
12.3 Meril Life Science
12.4 STENTYS S.A.
12.5 Cook Medical Inc
12.6 Lepu Medical Technology Co., Ltd.
Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
Market related information is congregated from both primary and secondary sources.
Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.